MedTrace Logo

The PROTECT-EU Study

NCT05466552 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 859

Last updated 2024-03-04

No results posted yet for this study

Summary

The PROTECT-EU Registry is a prospective, non-randomized, multi-national registry to evaluate 90 days outcomes in high risk-PCI (Percutaneous coronary intervention) patients treated with a preventive strategy with Impella CP® System.

Conditions

  • High-risk PCI

Interventions

PROCEDURE

PCI procedure

During the PCI procedure, use of ECMO/Impella 5.0 is allowed hemodynamic instability (bail- out).

Sponsors & Collaborators

  • Abiomed Inc.

    collaborator INDUSTRY

  • University of Padova

    collaborator OTHER

  • Fondazione GISE Onlus

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-18
Primary Completion
2024-06-01
Completion
2024-06-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05466552 on ClinicalTrials.gov